发明名称 Imidazoloisoquinolines
摘要 Disclosed are compounds of the formula: and the pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein n, R1, R2, R3, W, Q, and X are defined herein, which compounds bind with high selectivity and high affinity to the benzodiazepine site of the GABAA receptors and are therefore useful in the treatment of certain central nervous system (CNS) diseases and as probes for the localization of GABAA receptors in tissue samples.
申请公布号 US2002019410(A1) 申请公布日期 2002.02.14
申请号 US20010867304 申请日期 2001.05.29
申请人 NEUROGEN CORPORATION 发明人 CAI GUOLIN;SHAW KENNETH
分类号 A61P25/00;C07D217/24;C07D237/32;C07D471/04;C07D487/04;(IPC1-7):A61K31/474 主分类号 A61P25/00
代理机构 代理人
主权项
地址